List of Tables
Table 1. Ophthalmic Pharmaceutical Drugs Market Trends
Table 2. Ophthalmic Pharmaceutical Drugs Market Drivers & Opportunity
Table 3. Ophthalmic Pharmaceutical Drugs Market Challenges
Table 4. Ophthalmic Pharmaceutical Drugs Market Restraints
Table 5. Global Ophthalmic Pharmaceutical Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Ophthalmic Pharmaceutical Drugs Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Ophthalmic Pharmaceutical Drugs Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Ophthalmic Pharmaceutical Drugs Product Type
Table 9. Key Companies Time to Begin Mass Production of Ophthalmic Pharmaceutical Drugs
Table 10. Global Ophthalmic Pharmaceutical Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Pharmaceutical Drugs as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Ophthalmic Pharmaceutical Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2019-2024) & (%)
Table 27. Global Ophthalmic Pharmaceutical Drugs Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value, (2025-2030) & (US$ Million)
Table 31. Allergan PLC Basic Information List
Table 32. Allergan PLC Description and Business Overview
Table 33. Allergan PLC Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 34. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Allergan PLC (2019-2024)
Table 35. Allergan PLC Recent Developments
Table 36. Bayer AG Basic Information List
Table 37. Bayer AG Description and Business Overview
Table 38. Bayer AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 39. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Bayer AG (2019-2024)
Table 40. Bayer AG Recent Developments
Table 41. F. Hoffmann-La Roche AG Basic Information List
Table 42. F. Hoffmann-La Roche AG Description and Business Overview
Table 43. F. Hoffmann-La Roche AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 44. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of F. Hoffmann-La Roche AG (2019-2024)
Table 45. F. Hoffmann-La Roche AG Recent Developments
Table 46. Johnson and Johnson Vision Care Inc Basic Information List
Table 47. Johnson and Johnson Vision Care Inc Description and Business Overview
Table 48. Johnson and Johnson Vision Care Inc Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 49. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Johnson and Johnson Vision Care Inc (2019-2024)
Table 50. Johnson and Johnson Vision Care Inc Recent Developments
Table 51. Kyowa Kirin Co., Ltd Basic Information List
Table 52. Kyowa Kirin Co., Ltd Description and Business Overview
Table 53. Kyowa Kirin Co., Ltd Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 54. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Kyowa Kirin Co., Ltd (2019-2024)
Table 55. Kyowa Kirin Co., Ltd Recent Developments
Table 56. Novartis International AG Basic Information List
Table 57. Novartis International AG Description and Business Overview
Table 58. Novartis International AG Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 59. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Novartis International AG (2019-2024)
Table 60. Novartis International AG Recent Developments
Table 61. Pfizer, Inc. Basic Information List
Table 62. Pfizer, Inc. Description and Business Overview
Table 63. Pfizer, Inc. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 64. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Pfizer, Inc. (2019-2024)
Table 65. Pfizer, Inc. Recent Developments
Table 66. Regeneron Pharmaceuticals, Inc. Basic Information List
Table 67. Regeneron Pharmaceuticals, Inc. Description and Business Overview
Table 68. Regeneron Pharmaceuticals, Inc. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 69. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Regeneron Pharmaceuticals, Inc. (2019-2024)
Table 70. Regeneron Pharmaceuticals, Inc. Recent Developments
Table 71. Santen Pharmaceuticals Co., Ltd. Basic Information List
Table 72. Santen Pharmaceuticals Co., Ltd. Description and Business Overview
Table 73. Santen Pharmaceuticals Co., Ltd. Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 74. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Santen Pharmaceuticals Co., Ltd. (2019-2024)
Table 75. Santen Pharmaceuticals Co., Ltd. Recent Developments
Table 76. Shire PLC Basic Information List
Table 77. Shire PLC Description and Business Overview
Table 78. Shire PLC Ophthalmic Pharmaceutical Drugs Products, Services and Solutions
Table 79. Revenue (US$ Million) in Ophthalmic Pharmaceutical Drugs Business of Shire PLC (2019-2024)
Table 80. Shire PLC Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Ophthalmic Pharmaceutical Drugs Downstream Customers
Table 84. Ophthalmic Pharmaceutical Drugs Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Ophthalmic Pharmaceutical Drugs Product Picture
Figure 2. Global Ophthalmic Pharmaceutical Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Ophthalmic Pharmaceutical Drugs Report Years Considered
Figure 5. Global Ophthalmic Pharmaceutical Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmic Pharmaceutical Drugs Revenue in 2023
Figure 7. Ophthalmic Pharmaceutical Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Prescription Drugs Picture
Figure 9. Over-the-Counter Drugs Picture
Figure 10. Global Ophthalmic Pharmaceutical Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Ophthalmic Pharmaceutical Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital Pharmacies
Figure 13. Product Picture of Drug Stores
Figure 14. Product Picture of Online Pharmacies
Figure 15. Product Picture of Others
Figure 16. Global Ophthalmic Pharmaceutical Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Ophthalmic Pharmaceutical Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Ophthalmic Pharmaceutical Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Ophthalmic Pharmaceutical Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Ophthalmic Pharmaceutical Drugs Sales Value (%), (2019-2030)
Figure 29. United States Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 35. China Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 37. China Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. India Ophthalmic Pharmaceutical Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Ophthalmic Pharmaceutical Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. India Ophthalmic Pharmaceutical Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Ophthalmic Pharmaceutical Drugs Industrial Chain
Figure 51. Ophthalmic Pharmaceutical Drugs Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
